For all other variants—B.1.1.7, P.1, and B.1.351—although some patients developed sufficient nAb levels to block ACE2 binding to all variants that were well above the baseline, only P.1 was statistically different when comparing mild infection versus prepandemic samples (P = 0.03). The gene discussed is ACE2; the disease is infection.